HYLORIS PHARMACEUTIC

HYL
Real-time Quote. Real-time  - 08/11 03:28:51 am
13.78EUR +0.44%

Certain Shares of Hyloris Pharmaceuticals SA are subject to a Lock-Up Agreement Ending on 26-JUN-2022.

06/26/2022 | 12:00am
Certain Shares of Hyloris Pharmaceuticals SA are subject to a Lock-Up Agreement Ending on 26-JUN-2022. These Shares will be under lockup for 730 days starting from 26-JUN-2020 to 26-JUN-2022. Details: Pursuant to the lock-up arrangement, the holders of Locked Securities will not, for a period ending 360 days after the closing of the Offering, (i) directly or indirectly, issue, offer, pledge, exchange, lend, assign by way of security, grant any right, deliver or market, sell, contract to sell, sell or grant any option, right, warrant or contract to purchase, exercise any option to sell, purchase any option or contract to sell, or otherwise transfer or dispose of any of their Locked Securities, (ii) enter into any swap, any arrangement, any derivative transaction or issue any instruments that transfer (conditionally or unconditionally, now or in the future) to a third party all or part of the economic risk, benefits, rights or ownership of any Locked Securities, or (iii) publicly announce such an intention to effect any such transfer. Pursuant to this lock-up arrangement, each current Shareholder will not (i) take any action resulting in, which may result in, or having as goal, the transfer of a right in rem or any rights or obligations linked to the Conventionally Locked Securities, with or without consideration, including a sale, gift, contribution, swap, creation of a pledge or any other security interest, dissolution and liquidation, merger, demerger, transfer of (part of) the activity, divorce, death, seizure, the granting of purchase or sale options, and, in general, any acts or promised acts resulting in a certain or contingent event or immediate or future assignments, (ii) announce such an action or (iii) announce any intention thereto, with respect to: 66% of the relevant Shareholder's Conventionally Locked Securities: during the period starting on the date of expiry of the last to expire lock-up commitment of such shareholder vis-à-vis the Joint Global Coordinators and ending on the first anniversary of such date; and 33% of the relevant Shareholder's Conventionally Locked Securities: during the period starting on the first anniversary of the date of expiry of the last to expire lock-up commitment of such shareholder vis-à-vis the Joint Global Coordinators and ending on the second anniversary of such date.
© S&P Capital IQ 2022
Copier lien
All news about HYLORIS PHARMACEUTICALS SA
07/20
07/20
07/20
07/20
07/01